在5q脊柱肌肉缩的基因疗法后发生的血栓性微血管病变
Clara Gontijo Camelo1, Rodrigo Holanda Mendonça2,3, Cristiane Araújo Martins Moreno2
1Department of Neurology, Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, Brazil. claragc@gmail.com.
Gene therapy
|June 18, 2025
概括
血栓性微血管病变 (TMA) 是对脊髓肌肉缩 (SMA) 进行的onasemnogene abeparvovec (OA) 基因疗法的罕见但严重的副作用. 这项研究发现,TMA发生在巴西患者的2.4%中,这突显了迅速识别和管理的必要性.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 在asemnogene abeparvovec (OA) 是一种基因替代疗法,用于5q脊椎肌肉缩 (SMA).
- 病毒载体相关的血栓性微血管病变 (TMA) 是OA的严重但不太了解的副作用.
- 巴西SMA患者接受OA治疗的TMA的频率和临床概况以前没有评估过.
研究的目的:
- 为了确定TMA在巴西患者接受OA治疗SMA的频率.
- 在这个人群中描述TMA的临床和实验室特征.
- 确定潜在的风险因素,并为OA相关的TMA提供信息管理策略.
主要方法:
- 对294名巴西5q SMA患者进行了回顾性多中心研究,这些患者接受了OA治疗 (2020年10月 - 2024年9月).
- 对患有TMA的患者的临床数据,实验室结果和结果的分析.
- 在五名患者身上进行了整体外基因组测序,以调查遗传倾向.
主要成果:
- 七名患者 (2.4%) 在OA给药后发生了TMA.
- 输液后6-10天出现TMA症状,其特点是血液溶解性贫血,血栓塞缩和器官功能障碍.
- 在三名患者中发现了输注前感染;通过整个外体序列测序,没有通过TMA发现与TMA相关的致病变体.
结论:
- TMA是对SMA进行的异常治疗的罕见但显著的并发症.
- 早期检测和干预,特别是用皮质类固醇,对于管理TMA和改善患者结果至关重要.
- 需要进一步的研究来阐明病理生理学,并确定在接受OA的患者中TMA的特定风险因素.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Vascular Spasm
1.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.9K


